DALLAS, August 14, 2014 /PRNewswire/ --
According to the new market research report "Whole Exome Sequencing Market by Product [Systems, Kits (Library Preparation, Target Enrichment)], by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018", published by MarketsandMarkets, The Whole Exome Sequencing Market was valued at $326.6 Million in 2013 and is poised to grow at a CAGR of 22%, to reach $884.1 Million by 2018.
Browse 80 market Data Tables and 26 Figures spread through 220 Pages and in-depth TOC on "Whole Exome Sequencing Market"
Early buyers will receive 10% customization on this report.
The global Whole Exome Sequencing Market is segmented on the basis of technology, products and services, applications, end users, and geography. Based on technology, the Whole Exome Sequencing Market is divided between sequencing by synthesis and sequencing by ion semiconductor. Based on products and services, the Whole Exome Sequencing Market comprises instruments/platforms/sequencers, kits, sequencing services and data analysis services. Whole exome sequencing kits are further classified into DNA fragmentation, end repair, A-Tailing and size selection, library preparation kits and target enrichment kit.
Based on applications, the Whole Exome Sequencing Market is segmented into diagnostics, drug discovery and development, personalized medicine, and agriculture and animal research, among others. The market, by end users, is classified into research centers, academic and government institutions, hospitals and clinics, and pharmaceutical and biotechnology companies.
Based on geography, the market is divided into North America, Europe, Asia, and Rest of the World (RoW). North America is the largest market for whole exome sequencing, followed by Europe and Asia. The Asian market is slated to grow at the highest rate over the next five years.
Over the years, the demand for whole exome sequencing instruments, kits and services is likely to increase. Factors such as the rapidly decreasing costs of sequencing, adoption of WES technology by new consumers, strategic alliances amongst key players and research institutes, and increase in utilization of WES technology for new scientific applications are driving this demand for whole exome sequencing. The most important factor increasing the preference of WES over whole genome sequencing is its low-cost sequencing capability. However, a lack of skilled professionals and high reliability on government grants are some of the factors hindering the growth of the WES market.
Major players in the global Whole Exome Sequencing Market include Illumina, Inc. (U.S.) Life Technologies (acquired by Thermo Fisher Scientific, Inc.) (U.S.), Roche NimbleGen, Inc. (U.S.), Agilent Technologies (U.S.), BGI (Beijing Genomics Institute, China), Eurofins Genomics, Inc. (Germany), Sengenics (U.S.), GENEWIZ, Inc. (U.S.), Knome, Inc. (U.S.), Macrogen, Inc. (South Korea), and Ambry Genetics (U.S.), among others.
Browse related reports
Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] - Global Forecast to 2017
Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, healthcare IT semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology